Winston Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 26-04-2024
- Paid Up Capital ₹ 5.11 Cr
as on 26-04-2024
- Company Age 28 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 6.92 Cr
as on 26-04-2024
- Revenue -30.10%
(FY 2021)
- Profit -1273.05%
(FY 2021)
- Ebitda -301.58%
(FY 2021)
- Net Worth -6.09%
(FY 2021)
- Total Assets -31.37%
(FY 2021)
About Winston Pharmaceuticals
- CIN/LLPIN
U24231MH1996PLC360820
- Company No.
020204
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
24 Jun 1996
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Gautam Buddha Nagar, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Winston Pharmaceuticals Limited offer?
Winston Pharmaceuticals Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Kidney Drugs, Anti Infective Drugs & Medicines, Malaria Medicine, Antibiotic Injection, Health Conditions, Liver Care, Vitamins & Supplements, Vitamins A-Z, Pain Relief.
Who are the key members and board of directors at Winston Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajiv Sharma  | Director | 26-Feb-2015 | Current |
| Rajesh Kumar | Director | 24-Dec-2020 | Current |
| Ranjana Sharma | Director | 12-Jan-2018 | Current |
| Hitesh Bhandari | Director | 24-Dec-2020 | Current |
Financial Performance and Corporate Structure Insights of Winston Pharmaceuticals.
Winston Pharmaceuticals Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 30.1% decrease. The company also saw a substantial fall in profitability, with a 1273.05% decrease in profit. The company's net worth dipped by a decrease of 6.09%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Winston Pharmaceuticals?
In 2020, Winston Pharmaceuticals had a promoter holding of 53.30% and a public holding of 46.70%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rv Lifesciences LimitedActive 33 years 2 monthsRajesh Kumar, Rajiv Sharma and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 21 Jun 2017 | ₹1.76 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 06 Jun 2016 | ₹1.98 Cr | Satisfied |
Union Bank Of India Creation Date: 30 Sep 2014 | ₹3.00 M | Satisfied |
How Many Employees Work at Winston Pharmaceuticals?
Winston Pharmaceuticals has a workforce of 58 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Winston Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Winston Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
